title: Incidence and clinical presentation of moderate to severe graves' orbitopathy in a Danish population before and after iodine fortification of salt.
abstract: BACKGROUND
  Population-based data on the incidence and clinical presentation of moderate to severe Graves' orbitopathy (GO) are scarce, and virtually nothing is known on the effect of an iodization program on the incidence and presentation of GO.
  
  
  OBJECTIVE
  The objective of the study was to characterize incident moderate to severe GO in North Jutland County, Denmark, during the period 1992-2009, before and after the Danish salt iodization program.
  
  
  METHODS
  The design of the study was a prospective register of patients with incident moderate to severe GO in a population during 8.9 million persons × years of observation.
  
  
  METHODS
  The study was conducted at a thyroid-eye clinic of university hospital.
  
  
  METHODS
  Clinical presentation and incidence before and after the year 2000 initiation of the mandatory Danish iodization of salt were measured. The incidence of GO was related to the incidence of Graves' hyperthyroidism (GH) in the same population.
  
  
  RESULTS
  The incidence rate of moderate to severe GO was 16.1/million per year (women: 26.7; men: 5.4), with no change associated with iodization of salt. The moderate to severe GO incidence was 4.9% of the incidence of GH. The incidence rate ratio between women and men with GO (4.9) was not different from the ratio in GH. Compared with GH, only a few patients (<2%) suffered from moderate and severe GO below the age of 40 yr, whereas GO was relatively common in age groups 40-60 yr (∼8%).
  
  
  CONCLUSIONS
  Approximately 5% of the patients with Graves' disease develop moderate to severe GO, with a similar risk in women and men with Graves' disease. The risk of GO is much higher in patients aged 40-60 yr than in young patients with Graves' disease. Salt iodization was not associated with a change in the incidence of GO.
authors.affiliation: Department of Endocrinology, Aalborg Hospital, Aarhus University Hospital, DK-9000 Aalborg, Denmark. peter.laurberg@rn.dk
authors.forename: Peter
authors.initials: P
authors.lastname: Laurberg
authors.forename: Dalia C
authors.initials: DC
authors.lastname: Berman
authors.forename: Inge
authors.initials: I
authors.lastname: Bülow Pedersen
authors.forename: Stig
authors.initials: S
authors.lastname: Andersen
authors.forename: Allan
authors.initials: A
authors.lastname: Carlé
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D003718:Denmark / Q000453:epidemiology; D005260:Female; D006111:Graves Disease / Q000175:diagnosis / Q000178:diet therapy* / Q000453:epidemiology*; D049970:Graves Ophthalmopathy / Q000175:diagnosis* / Q000453:epidemiology* / Q000473:pathology / Q000517:prevention & control*; D006801:Humans; D015994:Incidence; D007455:Iodine / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D011153:Population; D012720:Severity of Illness Index; D017673:Sodium Chloride, Dietary / Q000008:administration & dosage*; D013997:Time Factors; D055815:Young Adult
chemical_list: D017673:Sodium Chloride, Dietary; C034024:iodized salt; D007455:Iodine